Key | % Net Assets |
---|---|
![]() |
8.1% |
![]() |
7.6% |
![]() |
5.8% |
![]() |
5.1% |
![]() |
73.4% |
Name | % Net Assets |
---|---|
GlaxoSmithKline | 8.1% |
AstraZeneca | 7.6% |
GlaxoSmithKline | 5.8% |
Roche | 5.1% |
BT | 5.1% |
Reynolds American | 4.8% |
Vodafone | 4.8% |
BG | 4.5% |
Reckitt Benckiser | 4.5% |
Imperial Tobacco | 4.2% |
No asset data available.
Date | 29-Apr-2025 |
---|---|
NAV | 3,311.94p |
Currency | GBP |
Change | 10.24p |
% | 0.31% |
YTD change | 93.81p |
YTD % | 2.92% |
Fund Inception | 16/06/1979 |
---|---|
Fund Manager | Neil Woodford |
TER | 1.69 (31-Dec-2013) |
Minimum Investment | |
---|---|
Initial | £500 |
Additional | £100 |
Savings | £20 |
Charges | |
---|---|
Initial | 5.00% |
Annual Mang't | 1.66% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.01 |
Sharpe ratio | 0.21 |
You are here: research